Your browser doesn't support javascript.
loading
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece.
Ragia, Georgia; Maslarinou, Anthi; Atzemian, Natalia; Biziota, Eirini; Koukaki, Triantafyllia; Ioannou, Charalampia; Balgkouranidou, Ioanna; Kolios, George; Kakolyris, Stylianos; Xenidis, Nikolaos; Amarantidis, Kyriakos; Manolopoulos, Vangelis G.
Afiliação
  • Ragia G; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Maslarinou A; Individualised Medicine and Pharmacological Research Solutions Center (IMPReS), Alexandroupolis, Greece.
  • Atzemian N; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Biziota E; Individualised Medicine and Pharmacological Research Solutions Center (IMPReS), Alexandroupolis, Greece.
  • Koukaki T; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Ioannou C; Individualised Medicine and Pharmacological Research Solutions Center (IMPReS), Alexandroupolis, Greece.
  • Balgkouranidou I; Department of Medical Oncology, University General Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Kolios G; Department of Medical Oncology, University General Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Kakolyris S; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Xenidis N; Department of Medical Oncology, University General Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Amarantidis K; Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Manolopoulos VG; Individualised Medicine and Pharmacological Research Solutions Center (IMPReS), Alexandroupolis, Greece.
Front Pharmacol ; 14: 1248898, 2023.
Article em En | MEDLINE | ID: mdl-37781702

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article